PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-9.52%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.63%
Negative EBIT growth while ON is at 7.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-17.63%
Negative operating income growth while ON is at 7.94%. Joel Greenblatt would press for urgent turnaround measures.
-4.84%
Negative net income growth while ON stands at 13.80%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.13%
Negative EPS growth while ON is at 12.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-2.52%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.41%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
29.35%
Dividend growth under 50% of ON's 255.58%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
101.67%
OCF growth above 1.5x ON's 43.69%. David Dodd would confirm a clear edge in underlying cash generation.
341.26%
FCF growth above 1.5x ON's 211.20%. David Dodd would verify if the firm’s strategic investments yield superior returns.
204.26%
10Y CAGR of 204.26% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
111.21%
Positive 5Y CAGR while ON is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
120.70%
Positive 3Y CAGR while ON is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
37.20%
OCF/share CAGR of 37.20% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
18.07%
Below 50% of ON's 708.27%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.81%
3Y OCF/share CAGR under 50% of ON's 159.65%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2571.27%
10Y net income/share CAGR of 2571.27% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
727.64%
5Y net income/share CAGR above 1.5x ON's 110.35%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
129.87%
3Y net income/share CAGR 50-75% of ON's 215.70%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
187.22%
Equity/share CAGR of 187.22% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
4.23%
Below 50% of ON's 71.03%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
69.04%
3Y equity/share CAGR at 75-90% of ON's 80.37%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
87.75%
Dividend/share CAGR of 87.75% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
75.60%
Dividend/share CAGR of 75.60% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
184.42%
3Y dividend/share CAGR of 184.42% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-15.08%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.62%
Inventory is declining while ON stands at 3.35%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.78%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.10%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
Our R&D shrinks while ON invests at 2.32%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.39%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.